Safety Study of Percutaneous Gastroscopic Gastrostomy in Patients After Ventriculoperitoneal Shunt

Objective To evaluate the safety study of percutaneous gastroscopic gastrostomy in patients after ventriculoperitoneal shunt. Methods We conducted a retrospective analysis of neurosurgical patients who underwent VPS and PEG at our hospital between January 2012 and November 2023. Patients were divide...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American surgeon 2024-12, Vol.90 (12), p.3262-3266
Hauptverfasser: Wang, Dexian, Peng, Run, Huang, Yebin, Zhou, Jun, Long, Zhihua, Wang, Jianjun, Zhang, Dejian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3266
container_issue 12
container_start_page 3262
container_title The American surgeon
container_volume 90
creator Wang, Dexian
Peng, Run
Huang, Yebin
Zhou, Jun
Long, Zhihua
Wang, Jianjun
Zhang, Dejian
description Objective To evaluate the safety study of percutaneous gastroscopic gastrostomy in patients after ventriculoperitoneal shunt. Methods We conducted a retrospective analysis of neurosurgical patients who underwent VPS and PEG at our hospital between January 2012 and November 2023. Patients were divided into 2 groups: VPS group and VPS followed by PEG gruop. Patients received routine antibiotic prophylaxis before the procedure, continued for 48 hours. Follow-up included monitoring immediate complications, particularly wound infection, intracranial infection, neurologic status deterioration, and shunt dysfunction. Routine follow-up visits were conducted post-discharge. Results In the VPS group (n = 778), the incidence of intracranial infection was 3.08%. Among patients with PEG after VPS, the time interval between procedures ranged from 13 to 685 days. The mean follow-up period was 22 (1-77) months, with no deaths or further complications. Conclusion Performing PEG more than 13 days after VPS does not significantly increase the risk of intracranial infections or PEG-associated infections, making it a relatively safe procedure.
doi_str_mv 10.1177/00031348241265147
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3082835032</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_00031348241265147</sage_id><sourcerecordid>3121198391</sourcerecordid><originalsourceid>FETCH-LOGICAL-c250t-1d3a366b6d2bcae19b320df107e1f7bc4c59b133f29c6509649e0334b591694b3</originalsourceid><addsrcrecordid>eNp1kUtLxDAQx4Mo7vr4AF4k4MVLNZNp2uYo4gsWFFa9liRNtdJt1iQ97Lc3y_oAxdPMML_5z4uQI2BnAGV5zhhDwLziOfBCQF5ukSkIITJZcdwm03U-WwMTshfCWwrzhO2SCUqGrCj5lOi5am1c0XkcmxV1LX2w3oxRDdaNgd6oEL0Lxi078xVEt1jRbqAPKnZ2iIFetNF6-px835mxd0vru-gGq3o6fx2HeEB2WtUHe_hp98nT9dXj5W02u7-5u7yYZYYLFjNoUGFR6KLh2igLUiNnTQustNCW2uRGSA2ILZemEEwWubQMMddCQiFzjfvkdKO79O59tCHWiy4Y2_ebZWpkFa9QMOQJPfmFvrnRD2m6GoEDyAolJAo2lElrB2_beum7hfKrGli9fkD95wGp5vhTedQL23xXfF08AWcbIKgX-9P2f8UPda2NWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3121198391</pqid></control><display><type>article</type><title>Safety Study of Percutaneous Gastroscopic Gastrostomy in Patients After Ventriculoperitoneal Shunt</title><source>MEDLINE</source><source>SAGE Complete A-Z List</source><creator>Wang, Dexian ; Peng, Run ; Huang, Yebin ; Zhou, Jun ; Long, Zhihua ; Wang, Jianjun ; Zhang, Dejian</creator><creatorcontrib>Wang, Dexian ; Peng, Run ; Huang, Yebin ; Zhou, Jun ; Long, Zhihua ; Wang, Jianjun ; Zhang, Dejian</creatorcontrib><description>Objective To evaluate the safety study of percutaneous gastroscopic gastrostomy in patients after ventriculoperitoneal shunt. Methods We conducted a retrospective analysis of neurosurgical patients who underwent VPS and PEG at our hospital between January 2012 and November 2023. Patients were divided into 2 groups: VPS group and VPS followed by PEG gruop. Patients received routine antibiotic prophylaxis before the procedure, continued for 48 hours. Follow-up included monitoring immediate complications, particularly wound infection, intracranial infection, neurologic status deterioration, and shunt dysfunction. Routine follow-up visits were conducted post-discharge. Results In the VPS group (n = 778), the incidence of intracranial infection was 3.08%. Among patients with PEG after VPS, the time interval between procedures ranged from 13 to 685 days. The mean follow-up period was 22 (1-77) months, with no deaths or further complications. Conclusion Performing PEG more than 13 days after VPS does not significantly increase the risk of intracranial infections or PEG-associated infections, making it a relatively safe procedure.</description><identifier>ISSN: 0003-1348</identifier><identifier>ISSN: 1555-9823</identifier><identifier>EISSN: 1555-9823</identifier><identifier>DOI: 10.1177/00031348241265147</identifier><identifier>PMID: 39030672</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Abdomen ; Adolescent ; Adult ; Aged ; Antibiotic Prophylaxis ; Antibiotics ; Catheters ; Cerebrospinal fluid ; Disease ; Dysphagia ; Endoscopy ; Female ; Fever ; Fistula ; Gastroscopy - adverse effects ; Gastroscopy - methods ; Gastrostomy - adverse effects ; Gastrostomy - methods ; Hemorrhage ; Humans ; Hydrocephalus ; Hypoxia ; Incidence ; Ischemia ; Leukocytes ; Male ; Middle Aged ; Neurological complications ; Neurosurgery ; Ostomy ; Patients ; Postoperative Complications - epidemiology ; Postoperative Complications - etiology ; Prophylaxis ; Retrospective Studies ; Shunts ; Staphylococcus infections ; Stroke ; Surgery ; Surgical outcomes ; Trauma ; Traumatic brain injury ; Tumors ; Ventriculoperitoneal shunt ; Ventriculoperitoneal Shunt - adverse effects ; Wound infection ; Young Adult</subject><ispartof>The American surgeon, 2024-12, Vol.90 (12), p.3262-3266</ispartof><rights>The Author(s) 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c250t-1d3a366b6d2bcae19b320df107e1f7bc4c59b133f29c6509649e0334b591694b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/00031348241265147$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/00031348241265147$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21818,27923,27924,43620,43621</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39030672$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Dexian</creatorcontrib><creatorcontrib>Peng, Run</creatorcontrib><creatorcontrib>Huang, Yebin</creatorcontrib><creatorcontrib>Zhou, Jun</creatorcontrib><creatorcontrib>Long, Zhihua</creatorcontrib><creatorcontrib>Wang, Jianjun</creatorcontrib><creatorcontrib>Zhang, Dejian</creatorcontrib><title>Safety Study of Percutaneous Gastroscopic Gastrostomy in Patients After Ventriculoperitoneal Shunt</title><title>The American surgeon</title><addtitle>Am Surg</addtitle><description>Objective To evaluate the safety study of percutaneous gastroscopic gastrostomy in patients after ventriculoperitoneal shunt. Methods We conducted a retrospective analysis of neurosurgical patients who underwent VPS and PEG at our hospital between January 2012 and November 2023. Patients were divided into 2 groups: VPS group and VPS followed by PEG gruop. Patients received routine antibiotic prophylaxis before the procedure, continued for 48 hours. Follow-up included monitoring immediate complications, particularly wound infection, intracranial infection, neurologic status deterioration, and shunt dysfunction. Routine follow-up visits were conducted post-discharge. Results In the VPS group (n = 778), the incidence of intracranial infection was 3.08%. Among patients with PEG after VPS, the time interval between procedures ranged from 13 to 685 days. The mean follow-up period was 22 (1-77) months, with no deaths or further complications. Conclusion Performing PEG more than 13 days after VPS does not significantly increase the risk of intracranial infections or PEG-associated infections, making it a relatively safe procedure.</description><subject>Abdomen</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Antibiotic Prophylaxis</subject><subject>Antibiotics</subject><subject>Catheters</subject><subject>Cerebrospinal fluid</subject><subject>Disease</subject><subject>Dysphagia</subject><subject>Endoscopy</subject><subject>Female</subject><subject>Fever</subject><subject>Fistula</subject><subject>Gastroscopy - adverse effects</subject><subject>Gastroscopy - methods</subject><subject>Gastrostomy - adverse effects</subject><subject>Gastrostomy - methods</subject><subject>Hemorrhage</subject><subject>Humans</subject><subject>Hydrocephalus</subject><subject>Hypoxia</subject><subject>Incidence</subject><subject>Ischemia</subject><subject>Leukocytes</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neurological complications</subject><subject>Neurosurgery</subject><subject>Ostomy</subject><subject>Patients</subject><subject>Postoperative Complications - epidemiology</subject><subject>Postoperative Complications - etiology</subject><subject>Prophylaxis</subject><subject>Retrospective Studies</subject><subject>Shunts</subject><subject>Staphylococcus infections</subject><subject>Stroke</subject><subject>Surgery</subject><subject>Surgical outcomes</subject><subject>Trauma</subject><subject>Traumatic brain injury</subject><subject>Tumors</subject><subject>Ventriculoperitoneal shunt</subject><subject>Ventriculoperitoneal Shunt - adverse effects</subject><subject>Wound infection</subject><subject>Young Adult</subject><issn>0003-1348</issn><issn>1555-9823</issn><issn>1555-9823</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUtLxDAQx4Mo7vr4AF4k4MVLNZNp2uYo4gsWFFa9liRNtdJt1iQ97Lc3y_oAxdPMML_5z4uQI2BnAGV5zhhDwLziOfBCQF5ukSkIITJZcdwm03U-WwMTshfCWwrzhO2SCUqGrCj5lOi5am1c0XkcmxV1LX2w3oxRDdaNgd6oEL0Lxi078xVEt1jRbqAPKnZ2iIFetNF6-px835mxd0vru-gGq3o6fx2HeEB2WtUHe_hp98nT9dXj5W02u7-5u7yYZYYLFjNoUGFR6KLh2igLUiNnTQustNCW2uRGSA2ILZemEEwWubQMMddCQiFzjfvkdKO79O59tCHWiy4Y2_ebZWpkFa9QMOQJPfmFvrnRD2m6GoEDyAolJAo2lElrB2_beum7hfKrGli9fkD95wGp5vhTedQL23xXfF08AWcbIKgX-9P2f8UPda2NWQ</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Wang, Dexian</creator><creator>Peng, Run</creator><creator>Huang, Yebin</creator><creator>Zhou, Jun</creator><creator>Long, Zhihua</creator><creator>Wang, Jianjun</creator><creator>Zhang, Dejian</creator><general>SAGE Publications</general><general>SAGE PUBLICATIONS, INC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>4T-</scope><scope>4U-</scope><scope>7QL</scope><scope>7T7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>202412</creationdate><title>Safety Study of Percutaneous Gastroscopic Gastrostomy in Patients After Ventriculoperitoneal Shunt</title><author>Wang, Dexian ; Peng, Run ; Huang, Yebin ; Zhou, Jun ; Long, Zhihua ; Wang, Jianjun ; Zhang, Dejian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c250t-1d3a366b6d2bcae19b320df107e1f7bc4c59b133f29c6509649e0334b591694b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Abdomen</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Antibiotic Prophylaxis</topic><topic>Antibiotics</topic><topic>Catheters</topic><topic>Cerebrospinal fluid</topic><topic>Disease</topic><topic>Dysphagia</topic><topic>Endoscopy</topic><topic>Female</topic><topic>Fever</topic><topic>Fistula</topic><topic>Gastroscopy - adverse effects</topic><topic>Gastroscopy - methods</topic><topic>Gastrostomy - adverse effects</topic><topic>Gastrostomy - methods</topic><topic>Hemorrhage</topic><topic>Humans</topic><topic>Hydrocephalus</topic><topic>Hypoxia</topic><topic>Incidence</topic><topic>Ischemia</topic><topic>Leukocytes</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neurological complications</topic><topic>Neurosurgery</topic><topic>Ostomy</topic><topic>Patients</topic><topic>Postoperative Complications - epidemiology</topic><topic>Postoperative Complications - etiology</topic><topic>Prophylaxis</topic><topic>Retrospective Studies</topic><topic>Shunts</topic><topic>Staphylococcus infections</topic><topic>Stroke</topic><topic>Surgery</topic><topic>Surgical outcomes</topic><topic>Trauma</topic><topic>Traumatic brain injury</topic><topic>Tumors</topic><topic>Ventriculoperitoneal shunt</topic><topic>Ventriculoperitoneal Shunt - adverse effects</topic><topic>Wound infection</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Dexian</creatorcontrib><creatorcontrib>Peng, Run</creatorcontrib><creatorcontrib>Huang, Yebin</creatorcontrib><creatorcontrib>Zhou, Jun</creatorcontrib><creatorcontrib>Long, Zhihua</creatorcontrib><creatorcontrib>Wang, Jianjun</creatorcontrib><creatorcontrib>Zhang, Dejian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The American surgeon</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Dexian</au><au>Peng, Run</au><au>Huang, Yebin</au><au>Zhou, Jun</au><au>Long, Zhihua</au><au>Wang, Jianjun</au><au>Zhang, Dejian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Safety Study of Percutaneous Gastroscopic Gastrostomy in Patients After Ventriculoperitoneal Shunt</atitle><jtitle>The American surgeon</jtitle><addtitle>Am Surg</addtitle><date>2024-12</date><risdate>2024</risdate><volume>90</volume><issue>12</issue><spage>3262</spage><epage>3266</epage><pages>3262-3266</pages><issn>0003-1348</issn><issn>1555-9823</issn><eissn>1555-9823</eissn><abstract>Objective To evaluate the safety study of percutaneous gastroscopic gastrostomy in patients after ventriculoperitoneal shunt. Methods We conducted a retrospective analysis of neurosurgical patients who underwent VPS and PEG at our hospital between January 2012 and November 2023. Patients were divided into 2 groups: VPS group and VPS followed by PEG gruop. Patients received routine antibiotic prophylaxis before the procedure, continued for 48 hours. Follow-up included monitoring immediate complications, particularly wound infection, intracranial infection, neurologic status deterioration, and shunt dysfunction. Routine follow-up visits were conducted post-discharge. Results In the VPS group (n = 778), the incidence of intracranial infection was 3.08%. Among patients with PEG after VPS, the time interval between procedures ranged from 13 to 685 days. The mean follow-up period was 22 (1-77) months, with no deaths or further complications. Conclusion Performing PEG more than 13 days after VPS does not significantly increase the risk of intracranial infections or PEG-associated infections, making it a relatively safe procedure.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>39030672</pmid><doi>10.1177/00031348241265147</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0003-1348
ispartof The American surgeon, 2024-12, Vol.90 (12), p.3262-3266
issn 0003-1348
1555-9823
1555-9823
language eng
recordid cdi_proquest_miscellaneous_3082835032
source MEDLINE; SAGE Complete A-Z List
subjects Abdomen
Adolescent
Adult
Aged
Antibiotic Prophylaxis
Antibiotics
Catheters
Cerebrospinal fluid
Disease
Dysphagia
Endoscopy
Female
Fever
Fistula
Gastroscopy - adverse effects
Gastroscopy - methods
Gastrostomy - adverse effects
Gastrostomy - methods
Hemorrhage
Humans
Hydrocephalus
Hypoxia
Incidence
Ischemia
Leukocytes
Male
Middle Aged
Neurological complications
Neurosurgery
Ostomy
Patients
Postoperative Complications - epidemiology
Postoperative Complications - etiology
Prophylaxis
Retrospective Studies
Shunts
Staphylococcus infections
Stroke
Surgery
Surgical outcomes
Trauma
Traumatic brain injury
Tumors
Ventriculoperitoneal shunt
Ventriculoperitoneal Shunt - adverse effects
Wound infection
Young Adult
title Safety Study of Percutaneous Gastroscopic Gastrostomy in Patients After Ventriculoperitoneal Shunt
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T18%3A32%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Safety%20Study%20of%20Percutaneous%20Gastroscopic%20Gastrostomy%20in%20Patients%20After%20Ventriculoperitoneal%20Shunt&rft.jtitle=The%20American%20surgeon&rft.au=Wang,%20Dexian&rft.date=2024-12&rft.volume=90&rft.issue=12&rft.spage=3262&rft.epage=3266&rft.pages=3262-3266&rft.issn=0003-1348&rft.eissn=1555-9823&rft_id=info:doi/10.1177/00031348241265147&rft_dat=%3Cproquest_cross%3E3121198391%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3121198391&rft_id=info:pmid/39030672&rft_sage_id=10.1177_00031348241265147&rfr_iscdi=true